Associated Papers
Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians.
Jadhao S et al.
Blood Advances, 2022
35420653 (PubMed )
Supplement: mmc1.xlsx › Supplementary_table3
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry.
Dumont M et al.
Cancers, 2022
35884425 (PubMed )
Supplement: cancers-14-03363-s001.zip › Table_S3-final_16052022.xlsx › Table_S3A
Genotyping of the ABCG2 gene using Matrix-Associated Laser Desorption/Ionisation, Time-of-Flight Mass Spectrometry.
Tanaka M et al.
Transfusion Medicine (oxford, England), 2018
Molecular analysis of immunized Jr(a-) or Lan- patients and validation of a high-throughput genotyping assay to screen blood donors for Jr(a-) and Lan- phenotypes.
Haer-Wigman L et al.
Transfusion, 2014
Defining the Jr(a-) phenotype in the Japanese population.
Tanaka M et al.
Transfusion, 2014
The JR blood group system (ISBT 032): molecular characterization of three new null alleles.
Hue-Roye K et al.
Transfusion, 2013
Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior.
Saison C et al.
Nature Genetics, 2012
Select a paper to view details